Target intelligence / Profile preview

REX1, RNA exonuclease 1 homolog pseudogene

Molecular classification
Other (pseudogene)
01

Overview

REX1, RNA exonuclease 1 homolog pseudogene (LOC100129276; ENSG00000230936) is classified as a pseudogene, meaning it is a genetic sequence similar to a protein-coding gene but is non-functional and does not produce a functional protein. There is no evidence for a direct biological or therapeutic role. It is not considered a drug target, biomarker, or contributor to any known disease process. The locus's nomenclature aligns it with the REXO1/REX1 exonuclease family, but, as a pseudogene, it is not involved in RNA processing or any exonuclease activity. This entry is not a real or functional molecular target; it is explicitly classified as a pseudogene in gene databases. There is no canonical abbreviation in widespread scientific use. Multiple RNase-related pseudogenes with similar names (such as REXO1L1P, REXO1L3P) exist, which can cause confusion, but ENSG00000230936/LOC100129276 specifically denotes a pseudogene. In summary, REX1, RNA exonuclease 1 homolog pseudogene is best classified as a non-functional pseudogene with no current evidence for use as a therapeutic target, disease biomarker, or drug interaction partner.

Other names
LOC100129276REX1 pseudogeneREXO1L1P

Beyond the preview

Go deeper on REX1, RNA exonuclease 1 homolog pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on REX1, RNA exonuclease 1 homolog pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call